Stakeholder Engagement in the Evidence-based Center (EPC) Practice Program
AHRQ's 2012 Annual Conference Slide Presentation
Select to access the PowerPoint® presentation (1.7 MB).
Slide 1

Engaging Stakeholders, Improving Research: Stakeholder Engagement in the Developing Evidence to Inform Decisions about Effectiveness (DEcIDE) Program
Jeanne-Marie Guise, MD, MPH
Professor
Oregon Health & Science University
Image: A cable car and a mountain in the background are shown.
Slide 2

Objectives
- Describe ways in which the EPC program has engaged stakeholders to improve relevance and applicability of its products.
- Present methods used for stakeholder engagement.
- Identify challenges in stakeholder engagement and strategies employed by the EPC program.
Slide 3

EPCs & SRC
Evidence-based Practice Centers (EPCs)
- 11 centers throughout the United States and Canada.
- Systematically and critically appraise existing research and synthesize knowledge.
- Produce comparative effectiveness and effectiveness reviews.
Scientific Resource Center (SRC)
- Responsible for scientific methodological work of reviews and other research projects for EPCs and DEcIDES.
Slide 4

EPCs & SRC
- Blue Cross and Blue Shield Association, Technology Evaluation Center, Chicago, IL.
- Brown University, Providence Rhode Island.
- ECRI Institute, Plymouth Meeting, PA.
- Johns Hopkins University, Baltimore, MD.
- Kaiser Foundation Research Institute, Oakland, CA.
- Oregon Health & Science University, Portland, OR.
- RTI International—University of North Carolina at Chapel Hill, Chapel Hill, NC.
- RAND Corporation, Santa Monica, CA.
- University of Alberta, Edmonton, Edmonton, Alberta.
- University of Minnesota EPC, Minneapolis, MN.
- Vanderbilt University Medical Center, Nashville, TN.
- Scientific Resource Center (SRC) for EPCs and DEcIDES—Portland VA Research Foundation, Portland OR.
Slide 5

Opportunities for Stakeholder Input
Image: At the center of the image is a green oval labeled "Public." Arrows point out from this oval to other ovals in a circle around it. These ovals are labeled:
- Disseminate Reports.
- Nominate Review Topics.
- Key Informants.
- Key Research Questions.
- Technical Expert Panel.
- Peer and Public Review.
- Feedback on Summary Guides.
- Future Research.
Slide 6

EHC Report on Engaging Stakeholders for Development and Prioritization of Future Research Needs
- O'Haire C, McPheeters M, Nakamoto E, LaBrant L, Most C, Lee K, Graham E, Cottrell E, Guise J-M. Engaging Stakeholders To Identify and Prioritize Future Research Needs. Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 Jun. (Methods Future Research Needs Reports, No. 4.) Available from: http://www.ncbi.nlm.nih.gov/books/NBK62565.
Slide 7

Image: A chart displays the following process:
Phase I: Literature Summary (Oregon EPC) →
- Literature Search →
- Literature Review →
- Literature Synthesis →
Phase II: Key Informant Interviews (Oregon EPC) →
- Recruitment and Interview Guide Development →
- Key Informant Interviews →
- Analysis of Interviews →
Phase III: EPC interviews (Vanderbilt EPC) →
- EPC Protocol Review →
- Invitations and EPC Discussion Guide →
- EPC Discussions →
- Analysis of Discussions →
All three sets of phases lead to Cumulative Synthesis.
Slide 8

Research Needs Development
Stakeholder Identification & Recruitment
- Identify pertinent stakeholder groups (intentional based upon stakeholder groupings).
- Ensure a balance of stakeholder perspectives (i.e., consumer, clinician, researcher, research funder, insurer/payer, manufacturer).
- The results of EPC FRN pilot projects suggest that engaging 6-10 stakeholders is appropriate.
- OMB restricts the number of participants in surveys to no more than 9 non-federal employees.
Slide 9

Stakeholders
| Stakeholder Group | Description |
|---|---|
Consumer | An individual or advocacy group representing individuals who have a health condition, use health care services and/or who are members of the community |
Clinician | Health care or public health provider (e.g., academic, rural/frontier, and community) and medical and/or public health organizations |
Social Service Organizations | An individual or organization that advances human welfare or social work (e.g. community or condition service providers, school-based programs, justice system) |
| Policymaker | An individual or organization who is involved in health care policy (e.g. local, state, provincial and Federal legislators and staff)
|
| Researcher | An individual who conducts and/or facilitates research activities in:
|
| Research Funder | A public or private organization that funds research (e.g. National Institute of Health, Susan G. Komen Foundation, and American Cancer Society) |
Insurer/Payer | An organization or agency that pays for health-related goods and services (e.g. Blue Cross Blue Shield, Medicaid, and Medicare) or a business group that pays for health insurance (e.g. employers and government) |
Manufacturer | A business group that produces health-related items (e.g. pharmaceuticals and medical devices) |
Slide 10

Methods of Stakeholder Engagement
Engagement
- Most common: Focus Groups, Symposia/Conferences.
Prioritization
- Most common: Priority Questionnaire, Consensus.
Engagement & Prioritization Simultaneously
- Priority Survey.
- Delphi.
Slide 11

| 1:1 Meetings | 1:1 Meetings (Phone) | Focus Groups | Group Calls | Symposia | Consensus or Voting | Survey | Delphi | |
|---|---|---|---|---|---|---|---|---|
| Short Timeframe | Poor | Good | Fair | Good | Fair | Fair | Good | Fair |
| ↓Budget | Fair | Good | Poor | Good | Fair | Fair | Good | Fair |
| Geographic Barriers | Poor | Good | Fair | Good | Fair | Fair | Good | Good |
| Differing Perspectives | Good | Good | Fair | Fair | Good | Fair | Good | Good |
| Multiple Stakeholder Groups | Good | Good | Fair | Fair | Good | Fair | Good | Good |
| ↓Research Experience | Good | Good | Good | Fair | Good | Fair | Fair | Poor |
| Complex Program | Good | Good | Good | Fair | Good | Fair | Poor | Fair |
Slide 12

EHC Program Research Reviews
Topic Generation:
- Nominate topics via the Web.
Topic Development:
- Clarify nomination intent.
- Frame clinical context of nomination.
Topic Refinement:
- Provide "real world" input.
- Provide input on clinical logic.
- Public comment via Web.
Review:
- Provide methodological & clinical input.
- Provide input via peer review.
- Provide public comment via Web.
Research Needs Development:
- Participate in discussions to describe research gaps & prioritize research needs.
Report Translation & Dissemination:
- Participate in focus groups.
- Participate in individual interviews.
- Provide expert review of summary guides.
Image: A large arrow points from left to right across the top of these listed items. It is captioned along its length with "Topics," "Evidence Review," "Research," and "D&I."
Slide 13

Topic Generation Approaches
Nominal Group Process
- In-person.
- Idea generating.
- Intended to promote group participation
Our experience:
In-person brainstorming with flip chart used to document topics
Each state had 8 stickers to vote for priority topics:
#1 (2 red dots)
#2 (2 green dots)
#3 (2 blue dots), and
#4 (2 yellow dots)
Weighting system applied to priorities:
#1—4 points for each vote
#2—3 points
#3—2 points
#4—1 point
Images: Three photographs show the stickers with topic ideas, first as individual responses, then grouped for clarification and consolidation of ideas, then ranked.
Slide 14

Topic Generation Approaches
Medicaid Medical Directors
Analytic Process:
Weighting system:
#1—4 points
#2—3 points
#3—2 points
#4—1 point
| Topics | |
| 83 PTS | Medical & Behavioral Health Integration/Coordination/Evidence |
| 67 PTS | Microarray Genetic Testing/Genetic Testing |
| 44 PTS | Emergency Room Use Reduction |
| 41 PTS | Long Term Care: Evidence and Monitoring Outcomes |
| 31 PTS | Obesity Treatment (Increasing Multicultural Understanding) |
| 29 PTS | Opiate Control / Narcotics / Chronic Pain Services / High Dose Opiates / Narcotics Appropriate for Non-cancer Patients |
| 23 PTS | Medical Home: Engagement of Participants & Implementation |
| 23 PTS | Autism: Untested Treatments (Diet, Lab Testing, ABA) |
| 20 PTS | Prematurity Prevention / Infertility Treatments |
Slide 15

Topic Generation Approaches
Prevention in Women's Health
Modified Process:
- Local Key Informants.
- Three web meetings:
- May 11 – Framework & Initial Topics
(Extranet & email topic generation) - June 8 – Topic Generation
(Evidence Scan) - 13 v Final Prioritization.
- May 11 – Framework & Initial Topics
- Prioritization:
- Survey—survey monkey.
- Web whiteboard during 3rd meeting.
Image: The logo of Prevention in Women's Health is shown.
Slide 16

Scoping CER
Stakeholders Engaged in:
- Development of CER key questions.
- Refinement of topic.
- Review of Draft.
Methods used:
- Group or individual calls.
- Web-based forums with survey type format to provide responses.
Slide 17

Preparation of Stakeholders Is Critical:
- Assume that all stakeholders need orientation to the CER process.
- Very important for them to know where they fit in and what to expect from their feedback.
- Familiarity with research methods likely to be very variable.
- Conflicts of interest are to be expected with stakeholder groups, but must be disclosed.
Slide 18

Stakeholder Preparatory Materials
Topic Generation:
- Nominate topics via the Web.
Topic Development:
- Clarify nomination intent.
- Frame clinical context of nomination.
Topic Refinement:
- Provide "real world" input from provider, patient, and policy perspectives.
- Provide input on clinical logic.
- Public comment via Web.
Review:
- Provide methodological & clinical input as a TEP member.
- Provide input via peer review.
- Provide public comment via Web.
Research Needs Development:
- Participate in discussions to describe research gaps & prioritize research needs.
Report Translation & Dissemination:
- Participate in focus groups.
- Participate in individual interviews.
- Provide expert review of summary guides.
Slide 19

Stakeholder Preparatory Materials
| Where We Are in the Comparative Effectiveness Review Process | Name of Panel | EPC Role & What to Expect |
|---|---|---|
| Describe what has occurred to date |
|
|
Slide 20

Future Research Needs Development
Purpose:
- Comparative Effectiveness Reviews (CERs) critically appraise and synthesize bodies of literature and identify areas where research is lacking or insufficient in either quantity or quality.
- There are limitations in funds available to support research.
- To fully actualize their potential, CERs should be utilized to inform and guide future research.
- Future Research Needs (FRN) documents are designed to facilitate this process by engaging stakeholders to prioritize future research topics.
Slide 21

Future Research Needs Development
- Step 1: Research gaps from CER interviews.
- Step 2: Identify & recruit stakeholders.
- Step 3: Orient stakeholders to project.
- Step 4: Solicit input on gaps, generate topics.
- Step 5: Engage stakeholders to prioritize FRN (at least 2 rounds).
- Step 6: Categorize by PICOs.
- Step 7: Search for ongoing Research & Reviews.
- Step 8: Write up report.
- Step 9: Elicit stakeholder feedback.
- Step 10: Final report.
Slide 22

Research Needs Development
Combined Methods:
- Semi-structured interviews to identify topics.
- Modified Delphi process for prioritization.
Semi-structured interviews.
- Telephone.
- Conference calls.
- Webinars.
Delphi
- #1 Survey:
- Topics organized by PICOs.
- Likert Scale—6-point scale of no, low, highest priority.
- #2 Survey:
- Likert.
- Ranking.
- Indicate top 3 in order.
Slide 23

Research Needs Development
| Priority | Final Rank | Weighted Scorea |
|---|---|---|
| Studies to test clinical, institutional, or policy interventions to increase access to "safe" TOL | 1 | 72 |
Research on barriers to providing safe TOL, including factors that limit the ability of hospitals to meet the "immediately available" requirement | 2 | 51 |
Studies comparing outcomes for mother and infant in settings where physicians are "immediately available" vs. settings where physicians are "readily available" | 3 | 46 |
Studies to understand best practice models based on institutions that are currently offering safe TOL | 4 | 41 |
Development of standardized measures for short-and long-term maternal and infant outcomes | 5 | 41 |
Surveillance to determine long-term clinical outcomes of TOL vs. ERCD | 6 | 38 |
Research on how patients understand risk, how they respond to different ways of framing risk, and how best to communicate risks of TOL vs. ERCD | 7 | 37 |
Clinical and policy relevant studies to address the threat of legal liability on practice patterns regarding TOL vs. ERCD | 8 | 34 |
Development/utilization of a reliable model or tool to predict the probability of successful VBAC for individual women /tool to predict probability of successful VBAC | 9 | 32 |
Studies to refine, validate, and implement informed consent templates that are informative, reliable, and able to be well documented | 10 | 26 |
Slide 24

Research Needs Development
Image: A double-headed arrow captioned "Research Continuum" extends above the following items:
Topic Generation →
- Clinicians.
- Consumers.
- Funders.
- Insurers.
- Researchers.
- Policymakers.
Research Prioritization →
- Clinicians.
- Consumers.
- Funders.
- Insurers.
- Manufacturers.
- Researchers.
- Payers.
- Policymakers.
Study Design →
- Clinicians.
- Manufacturers.
- Researchers.
- Policymakers.
Implementation →
- Clinicians.
- Consumers.
- Researchers.
- Policymakers.
Analysis/Interpretation →
- Clinicians.
- Researchers.
Dissemination →
- Clinicians.
- Consumers.
- Funders.
- Insurers.
- Manufacturers.
- Researchers.
- Payers.
- Policymakers.
A second double-headed arrow extends below these lists, with the text "EPC Stakeholder Engagement Expanded Scope of Future Research Needs Beyond CER."
Slide 25

Summary
- Several options for methods to use when engaging stakeholders.
- Method depends on several factors including:
- Intent (identifying topics, prioritization).
- Resources.
- Number and variety of stakeholders.
- What is already known in topic.
- Experience.
- Important to outline approach and intent a priori.
- Relationships with stakeholders are important:
- Contact potential stakeholders through multiple venues.
- Consistent communication and follow-up in the form of emails or phone calls is important to ensuring a balanced selection of stakeholders and a high response rate.
- Preparation of stakeholders is critical to define expectations and allow engagement.
